{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:23:45Z","timestamp":1788056625298,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["MR\/T006927\/1"],"award-info":[{"award-number":["MR\/T006927\/1"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["JS-BRC-1215-20017"],"award-info":[{"award-number":["JS-BRC-1215-20017"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NF-SI-0617-10077"],"award-info":[{"award-number":["NF-SI-0617-10077"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S004920\/1"],"award-info":[{"award-number":["MR\/S004920\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T006927\/1"],"award-info":[{"award-number":["MR\/T006927\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1162075"],"award-info":[{"award-number":["APP1162075"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Amyotrophic lateral sclerosis (ALS) is a prognostically heterogeneous neurodegenerative disease. Blood creatine kinase (CK) level has been inconsistently reported as a prognostic biomarker and raised levels in some ALS patients have been presumed to reflect muscle wasting, which is also variable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>MEDLINE was systematically searched for papers related to CK in ALS and the relevant studies were reviewed. Using data from 222 ALS patients in a multi-centre, prospective, longitudinal cohort, survival analyses using Kaplan\u2013Meier and Cox proportional hazards models were undertaken in relation to CK and other prognostic factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-five studies investigating CK in ALS were identified, of which 10 specifically studied the link between CK and survival. Five studies observed no association, four found that higher CK levels were associated with longer survival and one, the opposite. In our cohort (<jats:italic>n<\/jats:italic>\u2009=\u2009222), 39% of patients had a CK level above the laboratory reference range. Levels were higher in males compared to females (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), in patients with limb versus bulbar onset of symptoms (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and in patients with higher lower motor neuron burden (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). There was no significant trend in longitudinal CK values. Although a higher standardised log (CK) at first visit was associated with longer survival in univariate analysis (hazard ratio 0.75, <jats:italic>p<\/jats:italic>\u2009=\u20090.003), there was no significant association after adjusting for other prognostic covariates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>While raised CK levels in ALS do reflect lower motor neuron denervation to a large extent, they are not independently associated with survival when measured in the symptomatic phase of the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-022-11195-8","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T17:02:51Z","timestamp":1653498171000},"page":"5395-5404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis"],"prefix":"10.1007","volume":"269","author":[{"given":"Jiali","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanuja","family":"Dharmadasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Malaspina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1063-3277","authenticated-orcid":false,"given":"Alexander G.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"11195_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2 A, Logroscino G, Hardiman O et al (2009) Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10:310\u2013323. https:\/\/doi.org\/10.3109\/17482960802566824","journal-title":"Amyotroph Lateral Scler"},{"key":"11195_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","volume":"17","author":"H-J Westeneng","year":"2018","unstructured":"Westeneng H-J, Debray TPA, Visser AE et al (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17:423\u2013433. https:\/\/doi.org\/10.1016\/S1474-4422(18)30089-9","journal-title":"Lancet Neurol"},{"key":"11195_CR3","doi-asserted-by":"publisher","first-page":"s60","DOI":"10.7861\/clinmedicine.16-6-s60","volume":"16","author":"MR Turner","year":"2016","unstructured":"Turner MR (2016) Motor neuron disease: biomarker development for an expanding cerebral syndrome. Clin Med 16:s60\u2013s65. https:\/\/doi.org\/10.7861\/clinmedicine.16-6-s60","journal-title":"Clin Med"},{"key":"11195_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fneur.2019.00291","volume":"10","author":"NS Verber","year":"2019","unstructured":"Verber NS, Shepheard SR, Sassani M et al (2019) Biomarkers in motor neuron disease: a state of the art review. Front Neurol 10:291. https:\/\/doi.org\/10.3389\/fneur.2019.00291","journal-title":"Front Neurol"},{"key":"11195_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/bj2810021","volume":"281","author":"T Wallimann","year":"1992","unstructured":"Wallimann T, Wyss M, Brdiczka D et al (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the \u201cphosphocreatine circuit\u201d for cellular energy homeostasis. Biochem J 281:21\u201340","journal-title":"Biochem J"},{"key":"11195_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3949\/ccjm.83a.14120","volume":"83","author":"S Moghadam-Kia","year":"2016","unstructured":"Moghadam-Kia S, Oddis CV, Aggarwal R (2016) Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med 83:37\u201342. https:\/\/doi.org\/10.3949\/ccjm.83a.14120","journal-title":"Cleve Clin J Med"},{"key":"11195_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1212\/wnl.24.9.834","volume":"24","author":"AN Amrit","year":"1974","unstructured":"Amrit AN, Anderson MS (1974) Serum creatine phosphokinase in amyotrophic lateral sclerosis. Correlation with sex, duration, and skeletal muscle biopsy. Neurology 24:834\u2013837. https:\/\/doi.org\/10.1212\/wnl.24.9.834","journal-title":"Neurology"},{"key":"11195_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","volume":"66","author":"SY Kim","year":"2013","unstructured":"Kim SY, Park JE, Lee YJ et al (2013) Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 66:408\u2013414. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.09.016","journal-title":"J Clin Epidemiol"},{"key":"11195_CR9","doi-asserted-by":"publisher","first-page":"fcac029","DOI":"10.1093\/braincomms\/fcac029","volume":"4","author":"AG Thompson","year":"2022","unstructured":"Thompson AG, Gray E, Verber N et al (2022) Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain. Brain Commun 4:fcac029. https:\/\/doi.org\/10.1093\/braincomms\/fcac029","journal-title":"Brain Commun"},{"key":"11195_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265\u2013267. https:\/\/doi.org\/10.1212\/01.wnl.0000194316.91908.8a","journal-title":"Neurology"},{"key":"11195_CR11","doi-asserted-by":"publisher","first-page":"F632","DOI":"10.1152\/ajprenal.1984.247.4.F632","volume":"247","author":"P Boer","year":"1984","unstructured":"Boer P (1984) Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am J Physiol 247:F632-636. https:\/\/doi.org\/10.1152\/ajprenal.1984.247.4.F632","journal-title":"Am J Physiol"},{"key":"11195_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K (2011) mice: Multivariate Imputation by Chained Equations in R. J Stat Softw 45:1\u201367. https:\/\/doi.org\/10.18637\/jss.v045.i03","journal-title":"J Stat Softw"},{"key":"11195_CR13","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/sim.3618","volume":"28","author":"IR White","year":"2009","unstructured":"White IR, Royston P (2009) Imputing missing covariate values for the Cox model. Stat Med 28:1982\u20131998. https:\/\/doi.org\/10.1002\/sim.3618","journal-title":"Stat Med"},{"key":"11195_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/sim.4780100410","volume":"10","author":"DB Rubin","year":"1991","unstructured":"Rubin DB, Schenker N (1991) Multiple imputation in health-care databases: an overview and some applications. Stat Med 10:585\u2013598. https:\/\/doi.org\/10.1002\/sim.4780100410","journal-title":"Stat Med"},{"key":"11195_CR15","first-page":"189","volume":"43","author":"AF Lima","year":"2003","unstructured":"Lima AF, Evangelista T, de Carvalho M (2003) Increased creatine kinase and spontaneous activity on electromyography, in amyotrophic lateral sclerosis. Electromyogr Clin Neurophysiol 43:189\u2013192","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"11195_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/21678421.2015.1062516","volume":"16","author":"SB Gibson","year":"2015","unstructured":"Gibson SB, Kasarskis EJ, Hu N et al (2015) Relationship of creatine kinase to body composition, disease state, and longevity in ALS. Amyotroph Lateral Scler Frontotemporal Degener 16:473\u2013477. https:\/\/doi.org\/10.3109\/21678421.2015.1062516","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11195_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/ene.12995","volume":"23","author":"MK Rafiq","year":"2016","unstructured":"Rafiq MK, Lee E, Bradburn M et al (2016) Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis. Eur J Neurol 23:1071\u20131078. https:\/\/doi.org\/10.1111\/ene.12995","journal-title":"Eur J Neurol"},{"key":"11195_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/1673-5374.293159","volume":"16","author":"X-P Chen","year":"2021","unstructured":"Chen X-P, Wei Q-Q, Ou R-W et al (2021) Creatine kinase in the diagnosis and prognostic prediction of amyotrophic lateral sclerosis: a retrospective case-control study. Neural Regen Res 16:591\u2013595. https:\/\/doi.org\/10.4103\/1673-5374.293159","journal-title":"Neural Regen Res"},{"key":"11195_CR19","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1007\/s00415-019-09507-6","volume":"266","author":"D Ito","year":"2019","unstructured":"Ito D, Hashizume A, Hijikata Y et al (2019) Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis. J Neurol 266:2952\u20132961. https:\/\/doi.org\/10.1007\/s00415-019-09507-6","journal-title":"J Neurol"},{"key":"11195_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fneur.2017.00322","volume":"8","author":"H Tai","year":"2017","unstructured":"Tai H, Cui L, Guan Y et al (2017) Correlation of creatine kinase levels with clinical features and survival in amyotrophic lateral sclerosis. Front Neurol 8:322. https:\/\/doi.org\/10.3389\/fneur.2017.00322","journal-title":"Front Neurol"},{"key":"11195_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.clinph.2018.01.071","volume":"129","author":"H Tai","year":"2018","unstructured":"Tai H, Cui L, Liu M et al (2018) Creatine kinase level and its relationship with quantitative electromyographic characteristics in amyotrophic lateral sclerosis. Clin Neurophysiol 129:926\u2013930. https:\/\/doi.org\/10.1016\/j.clinph.2018.01.071","journal-title":"Clin Neurophysiol"},{"key":"11195_CR22","doi-asserted-by":"publisher","first-page":"E1174","DOI":"10.3390\/cells9051174","volume":"9","author":"M Ceccanti","year":"2020","unstructured":"Ceccanti M, Pozzilli V, Cambieri C et al (2020) Creatine kinase and progression rate in amyotrophic lateral sclerosis. Cells 9:E1174. https:\/\/doi.org\/10.3390\/cells9051174","journal-title":"Cells"},{"key":"11195_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000244","volume":"3","author":"C-H Lu","year":"2016","unstructured":"Lu C-H, Allen K, Oei F et al (2016) Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e244. https:\/\/doi.org\/10.1212\/NXI.0000000000000244","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11195_CR24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/jnnp-2018-318428","volume":"89","author":"RM Ahmed","year":"2018","unstructured":"Ahmed RM, Dupuis L, Kiernan MC (2018) Paradox of amyotrophic lateral sclerosis and energy metabolism. J Neurol Neurosurg Psychiatry 89:1013\u20131014. https:\/\/doi.org\/10.1136\/jnnp-2018-318428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11195_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/000456328802500411","volume":"25","author":"R Swaminathan","year":"1988","unstructured":"Swaminathan R, Ho CS, Donnan SPB (1988) Body composition and plasma creatine kinase activity. Ann Clin Biochem 25:389\u2013391. https:\/\/doi.org\/10.1177\/000456328802500411","journal-title":"Ann Clin Biochem"},{"key":"11195_CR26","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/acn3.51114","volume":"7","author":"E Gray","year":"2020","unstructured":"Gray E, Thompson AG, Wuu J et al (2020) CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 7:1296\u20131306. https:\/\/doi.org\/10.1002\/acn3.51114","journal-title":"Ann Clin Transl Neurol"},{"key":"11195_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ana.25276","volume":"84","author":"M Benatar","year":"2018","unstructured":"Benatar M, Wuu J, Andersen PM et al (2018) Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Ann Neurol 84:130\u2013139. https:\/\/doi.org\/10.1002\/ana.25276","journal-title":"Ann Neurol"},{"key":"11195_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0003-9993(86)90064-x","volume":"67","author":"M Sinaki","year":"1986","unstructured":"Sinaki M, Mulder DW (1986) Amyotrophic lateral sclerosis: relationship between serum creatine kinase level and patient survival. Arch Phys Med Rehabil 67:169\u2013171. https:\/\/doi.org\/10.1016\/0003-9993(86)90064-x","journal-title":"Arch Phys Med Rehabil"},{"key":"11195_CR29","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","volume":"71","author":"A Chi\u00f2","year":"2014","unstructured":"Chi\u00f2 A, Calvo A, Bovio G et al (2014) Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. JAMA Neurol 71:1134. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1129","journal-title":"JAMA Neurol"},{"key":"11195_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.14336\/AD.2017.1016","volume":"9","author":"Q-Q Wei","year":"2018","unstructured":"Wei Q-Q, Chen Y, Chen X et al (2018) Prognostic nomogram associated with longer survival in amyotrophic lateral sclerosis patients. Aging Dis 9:965\u2013975. https:\/\/doi.org\/10.14336\/AD.2017.1016","journal-title":"Aging Dis"},{"key":"11195_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174925","volume":"12","author":"M-L Ong","year":"2017","unstructured":"Ong M-L, Tan PF, Holbrook JD (2017) Predicting functional decline and survival in amyotrophic lateral sclerosis. PLoS\u00a0One 12:e0174925. https:\/\/doi.org\/10.1371\/journal.pone.0174925","journal-title":"PLoS\u00a0One"},{"key":"11195_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/acn3.51299","volume":"8","author":"Q-F Guo","year":"2021","unstructured":"Guo Q-F, Hu W, Xu L-Q et al (2021) Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 8:448\u2013455. https:\/\/doi.org\/10.1002\/acn3.51299","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11195-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T16:16:09Z","timestamp":1662999369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11195-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["11195"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11195-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"18 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Participants provided written informed consent and ethical approval for the study was obtained from London\u2014South East Research Ethics Committee (16\/LO\/2136).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}